Changes to Aetna’s National Precertification List (NPL)
These updates apply to both our commercial and Medicare members, unless otherwise noted.
Effective July 1, 2026, we’ll remove stimulated intrauterine insemination (iui), case rate (S4035).
Effective July 1, 2026, we’ll remove precertification for the following drug: Tegsedi® (inotersen) (J3490, J3590, C9399)